An integrated analysis identified collagen type I alpha 1 chain as a major component of the #ExtracellularMatrix that contributed to chemoresistance and poor prognosis, highlighting its potential as a therapeutic target. #OvarianCancer🎯
📍 https://t.co/zvnPUDszxQ
I'm always thrilled to celebrate the lab's accomplishments with this group of talented, dedicated, intelligent, and fun ladies at our annual winter holiday party. I'm excited to see even more of their achievements in 2025! ProudPI
The de la Puente Lab is hiring a postdoc. Are you interested in the ECM and it's role in cancer chemoresistance? Do you want to join our talented team? Apply! Please share the word
The @delapuente_lab attended the @AmericanCancer Hope Gala last weekend. An amazing event where the lab efforts where highlighted with a tribute video to our ScholarGrant, 1st of this kind given to SD. Our research efforts align with their mission to end cancer as we know it.
#BMES2024 is over and I want to highlight the amazing work done by @delapuente_lab members giving 7 killer oral talks, we also have fun visiting Baltimore, and connecting with old and new colleagues. Looking forward to #BMES2025 in SanDiego
Our newest publication is out @CMBEjournal! We present a microvascularized multiniche tumor-on-a-chip able to recapitulate spatial OC-TME compartmentalization, which directly influence drug resistance. Congrats @simastatina and @delapuente_lab https://t.co/U3g14DCwO6
De la Puente Lab 2024 summer Lab party was a success! Extremely grateful to be surrounded by a talented, smart and fun team #summervibes#fun&science #proudMentor